Diabetes, Vol 42, Issue 7 1055-1064, Copyright © 1993 by American Diabetes Association
Mechanisms of arterial hypotension after therapeutic dose of subcutaneous insulin in diabetic autonomic neuropathy
F Porcellati, C Fanelli, P Bottini, L Epifano, AM Rambotti, C Lalli, S Pampanelli, L Scionti, F Santeusanio, P Brunetti and al. et
Institute of Internal Medicine, University of Perugia, Italy.
To assess whether a therapeutic, subcutaneous injection of insulin exerts
hemodynamic effects in subjects with IDDM, 0.2 U/kg regular insulin was
injected subcutaneously in 17 IDDM subjects: 6 without autonomic
neuropathy, 7 with autonomic neuropathy and othostatic hypotension, and 4
with autonomic neuropathy but without orthostatic hypotension. Plasma
glucose was maintained at approximately 8.5 mM throughout the studies. Mean
blood pressure, plasma norepinephrine concentration, forearm vascular
resistances, and calf venous volume were measured before and 120 min after
subcutaneous insulin, in the supine position and 5 min after standing.
Supine plasma volume ([125I]albumin and [131I]albumin) was measured before
and after subcutaneous injection of insulin. In all three groups,
subcutaneous insulin activated the sympathetic nervous system
(approximately 30% increase in norepinephrine concentration). In subjects
with IDDM but without autonomic neuropathy, standing forearm vascular
resistance increased approximately 70% less after subcutaneous insulin, but
supine or standing mean blood pressure did not decrease. In contrast, in
subjects with IDDM with autonomic neuropathy and orthostatic hypotension,
subcutaneous insulin decreased supine mean blood pressure (from 99 +/- 3 to
94 +/- 5 mmHg) and exaggerated the standing decrement in mean blood
pressure (24 +/- 3 vs. 19 +/- 2 mmHg) (P < 0.05). This was associated
with a decrease in forearm vascular resistance. Similarly, in subjects with
IDDM with autonomic neuropathy without orthostatic hypotension,
subcutaneously injected insulin decreased supine mean blood pressure (from
95 +/- 2 to 89 +/- 2 mmHg) and standing mean blood pressure by 8 +/- 1 mmHg
(P < 0.05). Calf venous volume was not affected by subcutaneous insulin
in any of the three groups. Plasma volume did not change after subcutaneous
insulin in subjects with IDDM without autonomic neuropathy, whereas it
decreased in those with autonomic neuropathy and orthostatic hypotension
from 1.692 +/- 0.069 to 1.610 +/- 0.064 L/m2, without orthostatic
hypotension from 1.631 +/- 0.027 to 1.593 +/- 0.024 L/m2, P < 0.05). No
hemodynamic effects were observed when subjects with IDDM were restudied in
a control experiment where placebo (distilled water), not insulin, was
injected subcutaneously. In conclusion, therapeutic doses of subcutaneous
insulin activate the sympathetic nervous system; decrease blood pressure in
subjects with IDDM with autonomic neuropathy, but not in those without,
primarily by decreasing arterial vascular resistances and plasma volume;
and have no effects of capacitance vessels. Thus, in subjects with IDDM
without autonomic neuropathy, greater activation of sympathetic nervous
system after subcutaneous injection of insulin prevents orthostatic
hypotension.(ABSTRACT TRUNCATED AT 400 WORDS)